Human Vaccines & Immunotherapeutics
Optimizing pneumococcal prevention in South African older adults: Cost-effectiveness of PCV20 versus PPSV23 in the context of HIV-associated risk
Computational studyInterventions
The paper
Anhui Medical University
Human Vaccines & Immunotherapeutics, 8 Oct 2026



